ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,638, issued on March 3, was assigned to SHANGHAITECH UNIVERSITY (Shanghai).

"EGFR protein degradant and anti-tumor application thereof" was invented by Xiaobao Yang (Shanghai), Biao Jiang (Shanghai), Xiaoling Song (Shanghai), Ning Sun (Shanghai), Chaowei Ren (Shanghai), Renhong Sun (Shanghai), Xiaojuan Qu (Shanghai), Haixia Liu (Shanghai) and Xing Qiu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A bifunctional compound, or a pharmaceutically acceptable salt, an isomer, a prodrug, a polymorphic substance or a solvate thereof. The chemical structural formula of the bifunctional compound is represented as formula I, and the bifunctional com...